Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals...

FDA Recall #D-0096-2023 — Class III — December 27, 2022

Recall #D-0096-2023 Date: December 27, 2022 Classification: Class III Status: Terminated

Product Description

Prochlorperazine Maleate Tablets, USP 5mg, 100 tablets, RX Only, Jubilant Cadista Pharmaceuticals, Inc., Salisbury, Maryland 21801, NDC 59746-113-06

Reason for Recall

Subpotent Drug: Out of specification for assay at the 18-month stability timepoint.

Recalling Firm

Jubilant Cadista Pharmaceuticals, Inc. — Salisbury, MD

Classification

Class III — Not likely to cause adverse health consequences.

Product Type

Drugs

Product Quantity

14,061 bottles

Distribution

Nationwide in the USA.

Code Information

Lot#: 21P0336, Exp: 04/2023

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated